Yes, itchiness can be a side effect of lenalidomide (Revlimid), which is commonly used in maintenance therapy for multiple myeloma. Here are some steps you can take:

- Report to Your Oncologist: Inform your healthcare team about the itching. They may adjust your dosage or suggest alternative treatments
- At-Home Show Full Answer

Yes, itchiness can be a side effect of lenalidomide (Revlimid), which is commonly used in maintenance therapy for multiple myeloma. Here are some steps you can take:

- Report to Your Oncologist: Inform your healthcare team about the itching. They may adjust your dosage or suggest alternative treatments.
- At-Home Management: Use anti-itch creams, avoid heat, and consider taking over-the-counter medications like Benadryl, but only after consulting with your healthcare provider.

Always coordinate with your healthcare team before trying any new treatments.

 This AI-generated response comes from MyMyelomaTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Itchy Skin and Multiple Myeloma | MyMyelomaTeam

6 Facts About Myeloma Maintenance Therapy | MyMyelomaTeam